Underdiagnosis of familial hypercholesterolaemia: innovation is overdue-Reference-Cited by-同舟云学术

Underdiagnosis of familial hypercholesterolaemia: innovation is overdue

Published:2022-01-03 Issue: Volume: Page:
ISSN:0195-668X
Container-title:European Heart Journal
language:en
Short-container-title:

Author:

Bradley Corey K.¹^ORCID,Khera Amit²,Navar Ann Marie²^ORCID

Affiliation:

1. Department of Medicine, Columbia University Irving Medical Center, New York, NY 10032, USA

2. Department of Medicine, Division of Cardiology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine

Link

https://academic.oup.com/eurheartj/advance-article-pdf/doi/10.1093/eurheartj/ehab869/42011591/ehab869.pdf

Reference19 articles.

1. Clinical genetic testing for familial hypercholesterolemia: JACC Scientific Expert Panel;Sturm;J Am Coll Cardiol,2018

2. Abstract 19888: Improved longitudinal low density lipoprotein cholesterol goal achievement among familial hypercholesterolemia patients in the CASCADE FH patient registry;Duell;Circulation,2017

3. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: Executive Summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines;Grundy;J Am Coll Cardiol,2019

4. Application of pediatric and adult guidelines for treatment of lipid levels among US adolescents transitioning to young adulthood;Gooding;JAMA Pediatr,2015

5. Genetic identification of familial hypercholesterolemia within a single U.S. health care system;Abul-Husn;Science,2016

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. LDLR c.415G>A causes familial hypercholesterolemia by weakening LDLR binding to LDL;2024-01-09

2. Impact of educational attainment on preventive efforts after myocardial infarction: results of the IPP and NET-IPP trials;Clinical Research in Cardiology;2023-08-31

3. High-density lipoproteins, lipoprotein(a), and remnant cholesterol: new opportunities for reducing residual cardiovascular risk;European Heart Journal;2023-04-21

4. Screening, diagnosis, and treatment of familial hypercholesterolaemia: a call to action;European Heart Journal;2022-09-07

5. Implementation of a biochemical, clinical, and genetic screening programme for familial hypercholesterolemia in 26 centres in Spain: The ARIAN study;Frontiers in Genetics;2022-08-29